Clovis Oncology, Inc.
CLVS
CLVS was delisted on the 20th of December, 2022.
112 hedge funds and large institutions have $1.52B invested in Clovis Oncology, Inc. in 2013 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 60 increasing their positions, 21 reducing their positions, and 25 closing their positions.
186% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 21
11% more capital invested
Capital invested by funds: $1.36B → $1.52B (+$153M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 116 → 112 (-4)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
34% less call options, than puts
Call options by funds: $9.63M | Put options by funds: $14.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$30.3M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$28.3M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.1M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$12.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$23.4M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$10.3M |
| 3 |
PA
Perceptive Advisors
New York
|
-$8.93M |
| 4 |
HM
HealthCor Management
New York
|
-$8.56M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5.01M |
CLVS Hedge Fund Activity: Q4 2013 in Review
112 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q4 2013, worth a combined $1.52B — up 11% from $1.36B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of CLVS and 21 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 60 added.
The largest buyer was PFM Health Sciences, adding an estimated $30.3M. The largest seller was AllianceBernstein, cutting an estimated $23.4M.
- 112 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q4 2013, down from 116 in Q3 2013.
- Funds reported $1.52B of Clovis Oncology, Inc. stock for Q4 2013, up 11% quarter-over-quarter.
- 21 funds opened new Clovis Oncology, Inc. positions in Q4 2013 and 25 closed out, a net change of -4 holders.
- The largest Clovis Oncology, Inc. buyer in Q4 2013 was PFM Health Sciences, an estimated $30.3M added.
- The largest Clovis Oncology, Inc. seller in Q4 2013 was AllianceBernstein, an estimated $23.4M sold.
Based on aggregated 13F filings for Q4 2013.